Novel Antibody Platform Tackles Viral Mutations

Media Type
Article
Publish or Event Date
Research Institution
Icahn School of Medicine at Mount Sinai
Short Title
Novel Antibody Platform Tackles Viral Mutations
Content Coordinator
Content Manager

Maternal Antibodies Interfere with Malaria Vaccine Responses

Integral Molecular Secures $8 Million NIAID Contract to Combat Emerging Viruses

Fiocruz Will Lead the First Clinical Trial of a Leprosy Vaccine in Brazil

Design-Zyme, KU Collaboration Results in $3 Million SBIR Award for Lyme Disease Vaccine Development

Media Type
Article
Publish or Event Date
Research Institution
University of Kansas
Short Title
Design-Zyme, KU Collaboration Results in $3 Million SBIR Award for Lyme Disease Vaccine Development
Content Coordinator
Content Manager

Search Continues for a Treatment that Reduces Long COVID Symptoms

Duke Human Vaccine Institute to Develop Avian Flu Vaccine Protecting Against Variants, Provide Long-Lasting Immunity

Media Type
Article
Publish or Event Date
Research Institution
Duke Human Vaccine Institute
Short Title
Duke Human Vaccine Institute to Develop Avian Flu Vaccine Protecting Against Variants, Provide Long-Lasting Immunity
Content Coordinator
Content Manager

HPTN 091 Study Shows Encouraging Uptake and Adherence To Oral PrEP Among Transgender Women

Media Type
Article
Publish or Event Date
Research Institution
HPTN
Short Title
HPTN 091 Study Shows Encouraging Uptake and Adherence To Oral PrEP Among Transgender Women
Content Coordinator
Content Manager

Key Influenza-Severity Risk Factor Found Hiding in Plain Sight on Our Antibodies

Single Mutation in H5N1 Influenza Surface Protein Could Enable Easier Human Infection

A single modification in the protein found on the surface of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus currently circulating in U.S. dairy cows could allow for easier transmission among humans, according to new research funded by the National Institutes of Health (NIH) and published today in the journal Science. The study results reinforce the need for continued, vigilant surveillance and monitoring of HPAI H5N1 for potential genetic changes that could make the virus more transmissible in humans.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts